Trial Profile
Blood pressure and metabolic effects of nebivolol compared with hydrochlorothiazide and placebo in hypertensive patients with impaired glucose tolerance or impaired fasting glucose
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Feb 2020
Price :
$35
*
At a glance
- Drugs Nebivolol (Primary) ; Hydrochlorothiazide; Lisinopril; Losartan
- Indications Hypertension
- Focus Pharmacodynamics
- Sponsors Forest Laboratories
- 24 May 2011 Results presented at the 26th Annual Scientific Meeting of the American Society of Hypertension.
- 22 Sep 2010 Actual end date added to 1 Jul 2010 as reported by ClinicalTrials.gov.
- 22 Sep 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.